Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | 0.00% | +1.36% | -14.69% |
Sales 2021 | 92.96M 127M | Sales 2022 | 74.78M 102M | Capitalization | 37.73M 51.57M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | -41M -56.04M | EV / Sales 2021 | 1.11 x |
Net Debt 2021 | 73.28M 100M | Net Debt 2022 | 65.62M 89.7M | EV / Sales 2022 | 1.38 x |
P/E ratio 2021 |
38.2
x | P/E ratio 2022 |
-0.81
x | Employees | 398 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.35% |
Latest transcript on Trinity Biotech plc
1 week | +1.36% | ||
Current month | -10.29% | ||
1 month | -9.41% | ||
3 months | -12.86% | ||
6 months | -18.49% | ||
Current year | -14.69% |
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Cormac Reynolds
COO | Chief Operating Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.83 | 0.00% | 4,535 |
24-04-25 | 1.83 | 0.00% | 12,497 |
24-04-24 | 1.83 | 0.00% | 11,196 |
24-04-23 | 1.83 | +1.10% | 2,794 |
24-04-22 | 1.81 | +0.25% | 1,560 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-14.69% | 17.28M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- TRIB Stock